Number of the records: 1  

Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therpeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice

  1. NázovCombined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therpeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice
    Autor Giubellino Ad.
    Spoluautori Bullová Petra

    Noelting S.

    Turková H.

    Powers J.F.

    Liu Q.

    Guichard-Meili Jean

    Tischler G.

    Grossman Daniel

    Pacak K.

    Zdroj.dok. Endocrinology. Vol. 154, no. 2 (2013), p. 646 - 655
    Jazyk dok.eng - angličtina
    Druh dok.rozpis článkov z periodík (rbx)
    OhlasyMotylewska, E (Motylewska, Ewelina)[ 1 ] ; Lawnicka, H (Lawnicka, Hanna)[ 1 ] ; Kowalewicz-Kulbat, M (Kowalewicz-Kulbat, Magdalena)[ 2 ] ; Sicinska, P (Sicinska, Paulina)[ 3 ] ; Niedziela, A (Niedziela, Agata)[ 1 ] ; Melen-Mucha, G (Melen-Mucha, Gabriela)[ 1 ] ; Stepien, H Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro ENDOKRYNOLOGIA POLSKA Volume: 64 Issue: 5 Pages: 368-374,2013
    Leal, P (Leal, Pamela)[ 1 ] ; Garcia, P (Garcia, Patricia)[ 2 ] ; Sandoval, A (Sandoval, Alejandra)[ 1 ] ; Buchegger, K (Buchegger, Kurt)[ 1 ] ; Weber, H (Weber, Helga)[ 1 ] ; Tapia, O (Tapia, Oscar)[ 1 ] ; Roa, JC AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines ONCOTARGETS AND THERAPY Volume: 6 Pages: 1373-1384, 2013
    Gimenez-Roqueplo, AP (Gimenez-Roqueplo, Anne-Paule)[ 1,2,3 ] ; Favier, J New perspectives from genomics research for diagnosis and treatment of pheochromocytomas and paragangliomas CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION Volume: 17 Issue: 7 Pages: 203-207, 2013
    Francipane, MG (Francipane, Maria Giovanna)[ 1,2 ] ; Lagasse, E mTOR pathway in colorectal cancer: an update ONCOTARGET Volume: 5 Issue: 1 Pages: 49-66, 2014
    Lamming, DW (Lamming, Dudley W.)[ 1,2,3,4,5 ] ; Demirkan, G (Demirkan, Gokhan)[ 6,8 ] ; Boylan, JM (Boylan, Joan M.)[ 7,8 ] ; Mihaylova, MM (Mihaylova, Maria M.)[ 1,2,3,4,5 ] ; Peng, T (Peng, Tao)[ 1,2,3,4,5 ] ; Ferreira, J (Ferreira, Jonathan)[ 6 ] ; Neretti, N (Neretti, Nicola)[ 6 ] ; Salomon, A (Salomon, Arthur)[ 6 ] ; Sabatini, DM (Sabatini, David M.)[ 1,2,3,4,5 ] ; Gruppuso, PA Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2) FASEB JOURNAL Volume: 28 Issue: 1 Pages: 300-315, 2014
    Ghayee, HK Strategic Chemotherapy for Pheochromocytoma? ENDOCRINOLOGY Volume: 156 Issue: 11 Pages: 3880-3881, 2015
    Angelousi, A (Angelousi, Anna)[ 1 ] ; Kassi, E (Kassi, Evanthia)[ 2 ] ; Zografos, G (Zografos, Georgios)[ 3 ] ; Kaltsas, G Metastatic pheochromocytoma and paraganglioma EUROPEAN JOURNAL OF CLINICAL INVESTIGATION Volume: 45 Issue: 9 Pages: 986-997, 2015
    Farhan, MA (Farhan, Maikel A.)[ 1 ] ; Carmine-Simmen, K (Carmine-Simmen, Katia)[ 2 ] ; Lewis, JD (Lewis, John D.)[ 2 ] ; Moore, RB (Moore, Ronald B.)[ 3 ] ; Murray, AG Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis PLOS ONE Volume: 10 Issue: 8 Article Number: e0135245, 2015
    Favier, J (Favier, Judith)[ 1 ] ; Amar, L (Amar, Laurence)[ 2 ] ; Gimenez-Roqueplo, AP Paraganglioma and phaeochromocytoma: from genetics to personalized medicine NATURE REVIEWS ENDOCRINOLOGY Volume: 11 Issue: 2 Pages: 101-111, 2015
    Ortolani, S (Ortolani, Silvia)[ 1 ] ; Ciccarese, C (Ciccarese, Chiara)[ 1 ] ; Cingarlini, S (Cingarlini, Sara)[ 1 ] ; Tortora, G (Tortora, Giampaolo)[ 1 ] ; Massari, F Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives FUTURE ONCOLOGY Volume: 11 Issue: 12 Pages: 1809-1828, 2015
    Cheng, K. , Sun, F.-K. Role of PI3K/AKT/mTOR signaling pathway in development and progress of pheochromocytoma and its combined targeted therapies Journal of Shanghai Jiaotong University (Medical Science) Volume 35, Issue 1, 28 January 2015, Pages 137-141,
    Ghayee, H.K. Strategic chemotherapy for pheochromocytoma? Endocrinology Volume 156, Issue 11, November 2015, Pages 3880-3881
    Angelousi, A.a , Kassi, E.b, Zografos, G.c, Kaltsas, G. Metastatic pheochromocytoma and paraganglioma European Journal of Clinical Investigation Volume 45, Issue 9, 1 September 2015, Pages 986-997
    Ortolani, S., Ciccarese, C., Cingarlini, S., Tortora, G., Massari, F. Suppression of mTOR pathway in solid tumors: Lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives Future Oncology Volume 11, Issue 12, 1 June 2015, Pages 1809-1828
    KategóriaADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných
    Kategória (od 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Typ výstupučlánok
    Rok vykazovania2013
    Registrované vWOS
    Registrované vSCOPUS
    Registrované vCCC
    DOI 10.1210/en.2012-1854
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201320124.717Q12.207Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.